{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05220514",
            "orgStudyIdInfo": {
                "id": "21-008855"
            },
            "secondaryIdInfos": [
                {
                    "id": "R35NS097273",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R35NS097273"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Long-term Effects of COVID-19",
            "officialTitle": "Mayo Clinic Health System-wide Neurological, Vascular and Neurovascular Events With SARS-CoV-2- Part II",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other"
            ],
            "study": "long-term-effects-of-covid"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2022-01-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-01-10",
            "studyFirstSubmitQcDate": "2022-01-31",
            "studyFirstPostDateStruct": {
                "date": "2022-02-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Young M. Erben",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Neurological Disorders and Stroke (NINDS)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to measure, monitor, and analyze long term effects of SARS-CoV-2. The main purpose is to assess the post-hospitalization outcomes of patients who were diagnosed with SAR-CoV-2 by comparing to patients who were hospitalized with an acute neurological disease."
        },
        "conditionsModule": {
            "conditions": [
                "COVID-19",
                "SAR-CoV-2"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Non-COVID-19 Diagnosis Control Group",
                    "description": "Subjects hospitalized and receiving intensive care for diagnosis of an acute neurological disease other than COVID-19",
                    "interventionNames": [
                        "Drug: (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)",
                        "Drug: 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)"
                    ]
                },
                {
                    "label": "COVID-19 Diagnosis Case Group",
                    "description": "Subjects previously hospitalized at Mayo Clinic Hospital for treatment of PCR test confirmed COVID-19",
                    "interventionNames": [
                        "Drug: (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)",
                        "Drug: 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "(R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)",
                    "description": "Radiotracer used during the PET-MR scan of the study to identify signs of disease. Used in studies related to Alzheimer's disease. Only FDA approved for investigational use.",
                    "armGroupLabels": [
                        "COVID-19 Diagnosis Case Group",
                        "Non-COVID-19 Diagnosis Control Group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)",
                    "description": "Radiotracer used during the PET-MR scan of the study to identify signs of disease. Used in studies related to Alzheimer's disease. Only FDA approved for investigational use.",
                    "armGroupLabels": [
                        "COVID-19 Diagnosis Case Group",
                        "Non-COVID-19 Diagnosis Control Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Post-Covid Functional Status.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Questionnaire for Verifying stroke-free Status.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Patient Health Questionnaire.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Six-Item Screener.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Modified Rankin Scale.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Clinical Dementia Rating.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: National Institutes of Health Stroke Scale.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Neuropsychiatric Inventory Questionnaire.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Epworth Sleepiness Scale.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: National Alzheimer's Coordinating Center Unified Data Set",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Unified Parkinson Disease Rating Scale III.",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                },
                {
                    "measure": "Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19",
                    "description": "Collect participants' self reported response from questionnaire: Montreal Cognitive Assessment",
                    "timeFrame": "Baseline, 9 months, 12 months, 24 months."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Control Participants: Males and females over the age of 18 years hospitalized and receiving intensive care for diagnosis's other than COVID-19 or an acute neurological disease and who were not diagnosed (clinically or with PCR testing) with COVID-19.\n* Case Participants: Males and females over the age of 18 years who had been hospitalized at Mayo Clinic Hospital for treatment of COVID-19 confirmed by PCR test.\n* We acknowledge that some participants may be unable to consent due to underlying medical conditions; an eligible proxy may provide the informed consent and provide a signature on the designated line.\n* Women of childbearing age, between the ages of 18 to 55, must complete a negative pregnancy test.\n* Minority individuals over the age of 18 years will be eligible to enroll.\n\nExclusion Criteria:\n\n* Males and females, under the age of 18 years.\n* Participants with PET/MRI non-compatible devices.\n* Claustrophobia.\n* Allergies to study related procedures.\n* Pregnant , incarcerated, or institutionalized subjects will not be included in the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "A sample size of 100 patients hospitalized for COVID-19 with a subset of control patients hospitalized and receiving intensive care for diagnosis other than COVID-19 or an acute neurological disease.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jada McCullough",
                    "role": "CONTACT",
                    "phone": "(904) 953-4003",
                    "email": "McCullough.Jada@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Young Erben, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Florida",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Martin",
                            "role": "CONTACT",
                            "phone": "904-953-4003",
                            "email": "McCullough.Jada@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000086382",
                    "term": "COVID-19"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011024",
                    "term": "Pneumonia, Viral"
                },
                {
                    "id": "D000011014",
                    "term": "Pneumonia"
                },
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000018352",
                    "term": "Coronavirus Infections"
                },
                {
                    "id": "D000003333",
                    "term": "Coronaviridae Infections"
                },
                {
                    "id": "D000030341",
                    "term": "Nidovirales Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2561",
                    "name": "COVID-19",
                    "asFound": "COVID-19",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "relevance": "LOW"
                },
                {
                    "id": "M13914",
                    "name": "Pneumonia, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20490",
                    "name": "Coronavirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6555",
                    "name": "Coronaviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M23685",
                    "name": "Nidovirales Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000037850",
                    "term": "PK 11195"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M246344",
                    "name": "PK 11195",
                    "asFound": "PK11195",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}